Regulatory News
Monday, June 6, 2016
BRIEF-Ocular Therapeutix posts test results of allergic conjunctivitis treatment
* Ocular Therapeutix(tm) announces topline results of second
phase 3 clinical trial of Dextenza(tm) for the treatment of
allergic conjunctivitis
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment